CIK 0001048477
- Large accelerated filer
BIOMARIN PHARMACEUTICAL INC
Sign in to watch- Ticker
- BMRN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 680397820
- Phone
- +1 415-506-6700
- Business address
- 105 DIGITAL DRIVE, NOVATO, CA, 94949
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,466,459
- in 2 filings
Net −$1,466,459. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-01-13 | BIENAIME JEAN JACQUES Chief Executive Officer | Sale | −5,000 | $87.86 | $439K | 303,789 |
| 2022-01-13 | BIENAIME JEAN JACQUES Chief Executive Officer | Exercise or conversion · Stock Option (Right to buy Common Stock) | −5,000 | 115,000 | ||
| 2022-01-12 | BIENAIME JEAN JACQUES Chief Executive Officer | Exercise or conversion | +5,000 | $37.46 | $187K | 308,789 |
| 2022-01-12 | BIENAIME JEAN JACQUES Chief Executive Officer | Sale | −5,000 | $89.00 | $445K | 303,789 |
| 2022-01-12 | BIENAIME JEAN JACQUES Chief Executive Officer | Exercise or conversion · Stock Option (Right to buy Common Stock) | −5,000 | 120,000 | ||
| 2022-01-03 | Alles Mark J Director | Grant or award | +2,300 | 2,300 | ||
| 2021-12-21 | BIENAIME JEAN JACQUES Chief Executive Officer | Other acquisition | +100 | $89.22 | $9K | 303,789 |
| 2021-12-16 | BIENAIME JEAN JACQUES Chief Executive Officer | Exercise or conversion | +6,000 | $37.46 | $225K | 309,689 |
| 2021-12-16 | BIENAIME JEAN JACQUES Chief Executive Officer | Sale | −6,000 | $84.68 | $508K | 303,689 |
| 2021-12-16 | BIENAIME JEAN JACQUES Chief Executive Officer | Exercise or conversion · Stock Option (Right to buy Common Stock) | −6,000 | 125,000 | ||
| 2021-12-15 | BIENAIME JEAN JACQUES Chief Executive Officer | Exercise or conversion | +6,000 | $37.46 | $225K | 309,689 |
| 2021-12-15 | BIENAIME JEAN JACQUES Chief Executive Officer | Sale | −6,000 | $82.71 | $496K | 303,689 |
| 2021-12-15 | BIENAIME JEAN JACQUES Chief Executive Officer | Exercise or conversion · Stock Option (Right to buy Common Stock) | −6,000 | 131,000 | ||
| 2021-12-10 | BIENAIME JEAN JACQUES Chief Executive Officer | Gift | −700 | 303,689 | ||
| 2021-12-01 | BIENAIME JEAN JACQUES Chief Executive Officer | Sale | −1,500 | $87.22 | $131K | 304,389 |
| 2021-10-26 | Ajer Jeffrey Robert EVP, Chief Commercial Officer | Sale | −2,739 | $73.60 | $202K | 55,853 |
| 2021-10-20 | BIENAIME JEAN JACQUES Chief Executive Officer | Exercise or conversion | +1,000 | $37.46 | $37K | 305,839 |
| 2021-10-20 | BIENAIME JEAN JACQUES Chief Executive Officer | Exercise or conversion · Stock Option (Right to buy Common Stock) | −1,000 | 137,000 | ||
| 2021-09-09 | BIENAIME JEAN JACQUES Chief Executive Officer | Other acquisition | +50 | $78.77 | $4K | 305,889 |
| 2021-08-02 | Davis George Eric EVP, General Counsel | Sale | −5,518 | $76.69 | $423K | 58,590 |
Page 27 of 36 · 707 trades